Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Clinical trial NCT07444762 · COMPLETED

Trial details

NCT number: NCT07444762
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia Mixed Dyslipidemia

Start date: 2025-04-21
Primary completion: 2025-10-21
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.